New recombinant glycosylated prourokinase for treatment of patients with acute myocardial infarction
- 1 November 1994
- journal article
- clinical trial
- Published by Elsevier in Journal of the American College of Cardiology
- Vol. 24 (5) , 1242-1248
- https://doi.org/10.1016/0735-1097(94)90105-8
Abstract
No abstract availableKeywords
This publication has 40 references indexed in Scilit:
- Pro‐urokinase and prekallikrein are both associated with plateletsFEBS Letters, 1993
- Thrombolytic Therapy for Acute Myocardial InfarctionDrugs, 1992
- Clot-selective coronary thrombolysis with lowdose synergistic combinations of single-chain urokinase-type plasminogen activator and recombinant tissue-type plasminogen activatorThe American Journal of Cardiology, 1991
- Effect of combined administration of saruplase and single-chain alteplase on coronary recanalization in acute myocardial infarctionThe American Journal of Cardiology, 1989
- Low dose urokinase preactivated natural prourokinase for thrombolysis in acute myocardial infarctionThe American Journal of Cardiology, 1989
- Efficacy of intravenous prourokinase and a combination of prourokinase and urokinase in acute myocardial infarctionThe American Journal of Cardiology, 1988
- Recombinant single-chain urokinase-type plasminogen activator during acute myocardial infarctionThe American Journal of Cardiology, 1988
- Coronary arterial thrombolysis with low-dose synergistic combinations of recombinant tissue-type plasminogen activator (rt-PA) and recombinant single-chain urokinase-type plasminogen activator (rscu-PA) for acute myocardial infarctionThe American Journal of Cardiology, 1987
- Coronary thrombolysis in patients with acute myocardial infarction by intravenous infusion of synergic thrombolytic agentsAmerican Heart Journal, 1986
- The Thrombolysis in Myocardial Infarction (TIMI) TrialNew England Journal of Medicine, 1985